Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells

por Ucur, E, Mattern, J, Wenger, T, Okouoyo, S, Schroth, A, Debatin, K-M, Herr, I
Publicado 2003

Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo

por Gassler, N, Zhang, C, Wenger, T, Schnabel, P A, Dienemann, H, Debatin, K-M, Mattern, J, Herr, I
Publicado 2005

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

por Hage, C, Rausch, V, Giese, N, Giese, T, Schönsiegel, F, Labsch, S, Nwaeburu, C, Mattern, J, Gladkich, J, Herr, I
Publicado 2013

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas

por Salnikov, A V, Bretz, N P, Perne, C, Hazin, J, Keller, S, Fogel, M, Herr, I, Schlange, T, Moldenhauer, G, Altevogt, P
Publicado 2013

Enrichment of c-Met(+) tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib

por Liu, L, Aleksandrowicz, E, Fan, P, Schönsiegel, F, Zhang, Y, Sähr, H, Gladkich, J, Mattern, J, Depeweg, D, Lehner, B, Fellenberg, J, Herr, I
Publicado 2014

Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy

por Fan, P, Zhang, Y, Liu, L, Zhao, Z, Yin, Y, Xiao, X, Bauer, N, Gladkich, J, Mattern, J, Gao, C, Schemmer, P, Gross, W, Herr, I
Publicado 2016

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

por Beckermann, B M, Kallifatidis, G, Groth, A, Frommhold, D, Apel, A, Mattern, J, Salnikov, A V, Moldenhauer, G, Wagner, W, Diehlmann, A, Saffrich, R, Schubert, M, Ho, A D, Giese, N, Büchler, M W, Friess, H, Büchler, P, Herr, I
Publicado 2008